Budesonide/Salmeterol xinafoate

布地奈德/昔萘酸沙美特罗

Report date: 2025/11/27 15:17:34

Base Information

Drug NameBudesonide/Salmeterol xinafoate
Drug Alias NameLabazenitZephirus
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFinland
Original Approved Date2015/01/01
Country/TerritoryFinland
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Smb Sa
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Smb Sa
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AK06
Related LinksN/A